BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30783810)

  • 1. A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width.
    Bozkaya Y; Kurt B; Gürler F
    Int J Clin Oncol; 2019 Jul; 24(7):798-806. PubMed ID: 30783810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of baseline hemoglobin-to-red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis.
    Wu F; Yang S; Tang X; Liu W; Chen H; Gao H
    Thorac Cancer; 2020 Apr; 11(4):888-897. PubMed ID: 32087605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer.
    Chen JL; Wu JN; Lv XD; Yang QC; Chen JR; Zhang DM
    PLoS One; 2020; 15(8):e0237947. PubMed ID: 32833961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy.
    Palomar-Abril V; Soria-Comes T; Campos ST; Ureste MM; Bosch VG; Maiques ICM
    Clin Transl Oncol; 2020 Dec; 22(12):2333-2340. PubMed ID: 32449125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
    Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
    PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of pretreatment haemoglobin-to-red cell distribution width ratio for overall survival of patients with advanced non-small cell lung cancer: a propensity score matching analysis.
    Jiang H; Jiang W; Tan L; Yu Q; Liu F; Huang Y; He J; Zhou S
    J Int Med Res; 2021 Apr; 49(4):3000605211004229. PubMed ID: 33823630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?
    Bozkaya Y; Köstek O; Sakin A; Özyükseler DT; Şakalar T; Çil İ
    Support Care Cancer; 2020 May; 28(5):2273-2282. PubMed ID: 31471631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study.
    Yılmaz A; Mirili C; Tekin SB; Bilici M
    Ir J Med Sci; 2020 Feb; 189(1):91-102. PubMed ID: 31832860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer.
    İlhan A; Gurler F; Yilmaz F; Eraslan E; Dogan M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2060-2067. PubMed ID: 36930504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Prognostic Parameter Associated With Recurrence in Patients With Nasopharyngeal Cancer Treated With Chemoradiotherapy: The Ratio of the Hemoglobin-to-Red Cell Distribution Width.
    Bozkaya Y; Dilber M; Bilgili AM; Aktaş C
    Cureus; 2023 Jun; 15(6):e39907. PubMed ID: 37404429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy.
    Guo D; Li M; Chen D; Jing W; Zhu H; Fu L; Kong L; Yue J; Yu J
    Future Oncol; 2019 Feb; 15(6):625-635. PubMed ID: 30430864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
    Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
    Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of neuron-specific enolase in patients with advanced and metastatic non-neuroendocrine non-small cell lung cancer.
    Yan P; Han Y; Tong A; Liu J; Wang X; Liu C
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34286335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer.
    Yılmaz A; Yılmaz H; Tekin SB; Bilici M
    Biomark Med; 2020 Jun; 14(9):727-738. PubMed ID: 32648774
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral Blood Lymphocytes and Platelets Are Prognostic in Surgical pT1 Non-Small Cell Lung Cancer.
    Sulibhavi A; Asokan S; Miller MI; Moreira P; Daly BD; Fernando HC; Litle VR; Suzuki K
    Ann Thorac Surg; 2020 Feb; 109(2):337-342. PubMed ID: 31593659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
    Jiang AG; Chen HL; Lu HY
    BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation].
    Dong X; Zhou ZM; Bi N; Wang JB; Ran JT; Hui ZG; Liang J; Feng QF; Chen DF; Xiao ZF; Lyu JM; Wang XZ; Wang X; Zhang T; Deng L; Wang WQ; Wang LH
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):446-451. PubMed ID: 29936771
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer.
    Zhang H; Xia H; Zhang L; Zhang B; Yue D; Wang C
    Am J Surg; 2015 Sep; 210(3):526-35. PubMed ID: 26105800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy.
    Berardi R; Rinaldi S; Santoni M; Newsom-Davis T; Tiberi M; Morgese F; Caramanti M; Savini A; Ferrini C; Torniai M; Fiordoliva I; Bower M; Cascinu S
    Oncotarget; 2016 May; 7(18):26916-24. PubMed ID: 27029035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.